TREMFYA

• tagApproval56 co-mentions · 14 sources
• drugguselkumab56 co-mentions · 14 sources
• companyJanssen Biotech Inc28 co-mentions · 14 sources

Trials studying TREMFYA

• phase3A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Diseaserecruitingn=460
• phase3A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Diseaserecruitingn=120
• phase3A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Diseaserecruitingn=530
• phase3A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Diseaseactive not recruitingn=288
• N/AElucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapyrecruitingn=20
• phase3A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitisrecruitingn=644
• phase3A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitisactive not recruitingn=1,064
• phase3A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Diseaseactive not recruitingn=350